San Francisco, CA, United States of America

Floria Cheng

This inventor holds 37 USPTO granted patents and 13 published patent applications and 9 EPO patents, primarily in Anchor Delivery Systems. Top assignees: Neotract, Inc., Teleflex Life Sciences Pte. Ltd.. Active years: 2011-2025.

USPTO Granted Patents = 37 

% Patents Active = 91.9

 

Average Co-Inventor Count = 7.2

ph-index = 12

Forward Citations = 1,820(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Anchor Delivery System
Fiducial Marker
Benign Prostatic Hyperplasia
Median Lobe Destruction
Flexible Delivery Systems
Latching Anchor Device
Multi-Actuating Trigger
Suture Anchoring Devices
Continuous Indentation Apparatus
Median Lobe Band Implant
Incontinence Treatment
Deforming Anchor Device
37 patents (USPTO):Explore Patents

Title: Inventor Floria Cheng: Revolutionizing Technology in San Francisco

Introduction: Floria Cheng is a pioneering inventor based in San Francisco, CA, known for her groundbreaking contributions to the field of technology.

Latest Patents: Floria Cheng holds several patents in the realm of artificial intelligence and sustainable energy solutions, with her most recent patent focusing on a cutting-edge renewable energy storage system.

Career Highlights: With a career spanning over two decades, Floria Cheng has worked with top tech companies in Silicon Valley, leading research and development teams to create innovative solutions for complex technological challenges.

Collaborations: Throughout her career, Floria Cheng has collaborated with renowned scientists, engineers, and researchers from leading universities and research institutions worldwide, fostering a culture of innovation and knowledge sharing.

Conclusion: Floria Cheng's dedication to pushing the boundaries of technology and her relentless pursuit of innovation continue to inspire the next generation of inventors and engineers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…